Our Buyer ETF Base Has Expanded: AB's Gunts
Julie Gunts, global head of ETFs at AllianceBernstein, joins Scarlet Fu and Eric Balchunas on "Bloomberg ETF IQ."
Julie Gunts, global head of ETFs at AllianceBernstein, joins Scarlet Fu and Eric Balchunas on "Bloomberg ETF IQ."
Ben Hodges, a former commanding general for the US Army in Europe, said reports from the Trump administration on the conflict with Iran 'are not very closely connected to the truth on the ground.' General Hodges also said that he was 'encouraged' to hear reports that military leaders had pushed back on Defense Secretary Pete Hegseth and urged him to stop military extension of war with Iran.
Radiant has won a $750 million US Army contract to provide 15 portable nuclear microreactors under the Janus program. President and COO Tori Shivanandan discusses the technology behind the reactors, the military's push for resilient energy, and what Radiant needs to do next to scale production. She joins Ed Ludlow on "Bloomberg Tech."
The IA40 list from Madrona is back, spotlighting the private companies shaping the next phase of AI. Matt McIlwain, managing director at Madrona, explains how the list is assembled, why OpenAI, Anthropic and Databricks dominate AI fundraising, and how a successful Anthropic IPO could open the door for a new wave of public offerings in 2027. He joins Ed Ludlow on "Bloomberg Tech."
Nvidia makes another big bet on the future of AI with a $3.5 billion investment in MediaTek, as investors gear up for a potentially record-breaking Anthropic IPO. Forrester Research Founder and CEO George Colony weighs in on the AI boom, whether the hype is justified and what comes next. He speaks on Bloomberg Open Interest.
Eli Lilly & Co. plans to buy Merida Biosciences Inc. for as much as $2.88 billion in cash to expand in autoimmune and allergic diseases, part of an effort to build beyond the weight-loss and diabetes markets that made it the largest pharmaceutical company in the world. Lilly has been on a record spending spree, having announced more than $20 billion in deals so far in 2026. The drugmaker has been using the windfall from its Zepbound and Mounjaro shots to diversify its pipeline, mainly targeting medicines in earlier stages as it seeks to position itself to develop the next blockbuster medicine. For more, we speak with Michelle Cortez, Bloomberg News Senior Editor for Global Business.
Anthropic PBC's IPO is casting a long shadow over companies' US listing plans, as they try to find room for their deals to grab attention after the Sept. 7 Labor Day holiday. The Claude developer is preparing to file publicly for an initial public offering that's expected to raise as much as SpaceX's record $86.2 billion debut, if not more, in the coming weeks. Some firms and their backers are finding it hard to get the attention of long-term-oriented investors and sovereign wealth funds when the prospect of an Anthropic IPO is imminent, according to people familiar with the preparations. For a closer look, we speak with Bailey Lipschultz, Senior Equities Reporter for Bloomberg News.
President Trump is framing the deal for a US stake in 65 billion barrels of Venezuelan oil as a victory that will lower gasoline prices and replenish depleted crude reserves. It's far from certain the plan will lead to either during his presidency if at all. Trump pushed for a blockbuster move after growing frustrated that private oil companies, including ExxonMobil Holdings Corp. and ConocoPhillips, weren't moving quickly enough to boost production in Venezuela, according to people familiar with the matter. By starting a new venture directly controlled by the US, his administration is seeking to give producers more confidence to commit to developing the 17 oil fields involved in the deal. For more, we speak with Ellen Wald, President and Founder of Transversal Consulting & Senior Fellow at the Atlantic Council Global Energy Center.
The US Open is serving up a record $108 Million prize purse after years of players rallying for more money. Bloomberg's Shaquille Omari breaks down how much winners will take home this year.
Some investors are voicing skepticism about mounting speculation that Federal Reserve Chairman Kevin Warsh is poised to raise interest rates. After Warsh reiterated his commitment to bringing down inflation in a highly anticipated speech on Friday, swaps traders see a rate hike as more likely than not at the central bank's next decision in mid-September. Sarah Hunt, Chief Market Strategist at Alpine Saxon Woods, offers her equity outlook post-Jackson Hole.
Newell Brands President & CEO Chris Peterson joins Bloomberg Open Interest to break down the increasingly divided US consumer, explaining why higher-income shoppers are still spending while lower-income households remain pressured. He also talks about how AI slashed digital content costs by 80%, helping the Sharpie and Rubbermaid maker return to growth without widespread job cuts.
Timna Tanners, an analyst for Wells Fargo & Co., says Canada's retaliatory steel tariffs are mostly ``for show'' because the trade war with the US already has made American imports too costly. She speaks with Dani Burger and Sally Bakewell on Bloomberg's ``Open Interest.''
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy